Fiducial Markers Market: In-depth Analysis, Demand Statistics & Competitive Outlook 2022-2028

Comments · 5 Views

The fiducial markers market was estimated at USD 113.07 million in 2021 and is likely to grow at a CAGR of 4.34% during 2022-2028 to reach USD 152.77 million in 2028.

Stratview Research has recently added a new report titled ‘Fiducial Markers Market’ to its collection. The report studies vital factors about the market that are essential for existing players as well as new market entrants. The report throws light on critical elements such as market share, profitability, supply chain, production, sales, upcoming technologies, key market players, regional segmentation, and many more aspects related to the Fiducial Markers Market.

Market Highlights

The fiducial markers market was estimated at USD 113.07 million in 2021 and is likely to grow at a CAGR of 4.34% during 2022-2028 to reach USD 152.77 million in 2028.

What is a fiducial marker?

A fiducial marker is a medical device that is mainly placed on the object or body so that it can mark the area that needs to get surgery. These markers are very tiny equipment of the size of rice grains, which can help to target cancerous tumours or tissues without affecting the healthy ones. This device enables to mark off the exact position of the tumour and can help the doctor to provide maximum radiation dose to the particular area consisting of the tumour without harming the surrounding tissues.

The key players covered in this report are –

  • CIVCO Radiotherapy (The U.S),
  • IZI Medical Products (The U.S),
  • Naslund Medical AB (Sweden),
  • Medtronic, Inc. (Ireland),
  • QlRad Inc. (Netherlands),
  • QFix (The U.S),
  • Boston Scientific Corporation (The U.S),
  • Nanovi A/S (Denmark),
  • Eckert Ziegler (Belgium), and
  • IBA Dosimetry GmbH (Germany).

Market Dynamics

The growing adoption of radiotherapy devices by oncologists coupled with rising cases of cancer across the globe are the prime factors augmenting the product demand. Also, the surging demand for SBRT and IGRT procedures further boosts market growth.

Moreover, increasing awareness regarding the fiducial markers to give effective diagnosis further offers lucrative opportunities to the industry players. However, the requirement of placing fiducial markers before the CT scan will necessitate a second 3D scan before or during surgery can hamper the industry expansion.

About Stratview Research

Stratview Research is a global market research firm with capabilities of providing complex market reports and other consulting services. Along with market reports, the firm also provides custom research services across the sectors covering industries like Energy Chemicals, Advanced Materials, Automotive, and Aerospace, and more.

In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.